Nature, Published online: 23 July 2025; doi:10.1038/s41586-025-09303-5

An NNMT inhibitor reduces tumour burden and metastasis in multiple mouse cancer models and restores immune checkpoint blockade efficacy by decreasing cancer-associated-fibroblast-mediated recruitment of myeloid-derived suppressor cells and reinvigorating CD8+ T cell activation.


From Nature via this RSS feed